Medtronic Expands Stealth AXiS System to Cranial and ENT Procedures

Event summary

  • Medtronic received FDA clearance for its Stealth AXiS surgical system for cranial and ENT procedures on March 27, 2026.
  • The system unifies surgical planning, navigation, and robotics into a single intelligent platform.
  • AI-enabled architecture supports advanced planning and visualization before, during, and after surgery.
  • The system integrates intraoperative ultrasound through GE HealthCare's bkActiv.
  • Medtronic aims to deliver connected technologies supporting surgeons across multiple specialties on a single platform.

The big picture

Medtronic's FDA clearance for the Stealth AXiS system reinforces its strategy to deliver connected technologies across multiple surgical specialties. This move aligns with the broader industry trend towards AI-driven, integrated surgical platforms that enhance precision and efficiency. The system's flexible architecture positions Medtronic to shape the next era of surgery, potentially setting a new standard in cranial and ENT procedures.

What we're watching

Market Expansion
How Medtronic will leverage the Stealth AXiS system to capture market share in cranial and ENT procedures.
Technological Integration
Whether the AI-enabled architecture will drive significant adoption and improve surgical outcomes.
Competitive Dynamics
The pace at which competitors will respond with similar integrated surgical systems.

Related topics

Medical Devices